Business Wire - October 18, 2001
"WDI has built many valuable assets, such as its private sector distribution capabilities, its GLOBALeMED e-commerce platform, brand name and product registrations worldwide, and many key inroads for public sector business. The Company continues to concentrate on delivering rapid diagnostic tests for outbreak and disease states that represent key health concerns, particularly for the international community, that provide innovative low cost products for the identification and containment of global health concerns, including the latest health threats of bio-chemical public health conditions," commented Barry Peters, chairman of World Diagnostics.
Recently, WDI announced that it received its first approvals and authorization from the Drug Control Board in India to begin sales of three rapid diagnostic tests: Dengue Fever, a non-fatal outbreak disease, quite common in India; Troponin I, a widely used heart attack indicator and its pregnancy tests.
About WDI/GLOBALeMED.com
WDI is an innovative leader for providing a wide range of medical diagnostic and laboratory products worldwide, offering a simplified option, through its GLOBALeMED system, for purchasing medical laboratory and healthcare products and for professionals to access critical technical data and information, training aids and online customer support.
WDI's network of distributors and GLOBALeMED partners now covers 80 countries, offering the most comprehensive resource for most medical diagnostic tests and laboratory products, currently comprised of about 1,000 WDI branded products, and numerous other products, that are sold through distributors and directly to medical professionals, hospitals, physician offices, clinical laboratories, and retail drug stores.
WDI's vision is to become the premier resource for supplying diagnostic tests and allied medical laboratory products for the $5.0 billion emerging nation global marketplace. WDI is aggressively expanding its business and brand name through its distribution network and its GLOBALeMED e-commerce platform, which can be accessed at either www.worlddiagnostics.com or www.globalemed.com. WDI's GLOBALeMED Web site is the only multi-cultural, multi-lingual, medical information-based Web site of its kind, generating customer satisfaction and convenient transactional options and new business leads daily that contribute to WDI's growing customer base and name recognition.
Except for historical matters contained herein, the matters discussed in this news release are forward-looking statements and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect the assumptions and involve risk and uncertainties, which may affect World Diagnostics, Inc.'s business and prospects and cause actual results to differ materially from these forward-looking statements.
CONTACT: World Diagnostics, Inc Barry Peters, 310/234-9535 e-Mail: bpeters@worlddiagnostics.com
011018
BW011007
Copyright © 2001 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .